Singapore markets open in 4 hours

Acutus Medical, Inc. (AFIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8699-0.0101 (-1.15%)
At close: 04:00PM EDT
0.8499 -0.02 (-2.30%)
After hours: 04:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.79M
Enterprise value -24.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.56
Price/book (mrq)0.34
Enterprise value/revenue -1.45
Enterprise value/EBITDA 0.30

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 3-89.35%
S&P500 52-week change 3-16.62%
52-week high 39.1500
52-week low 30.4800
50-day moving average 31.2576
200-day moving average 31.5270

Share statistics

Avg vol (3-month) 3482.93k
Avg vol (10-day) 371.67k
Shares outstanding 528.37M
Implied shares outstanding 6N/A
Float 820.65M
% held by insiders 14.24%
% held by institutions 145.45%
Shares short (14 Sept 2022) 4829.87k
Short ratio (14 Sept 2022) 45.09
Short % of float (14 Sept 2022) 43.69%
Short % of shares outstanding (14 Sept 2022) 42.93%
Shares short (prior month 14 Aug 2022) 4980.34k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)-701.38%

Management effectiveness

Return on assets (ttm)-52.56%
Return on equity (ttm)-123.37%

Income statement

Revenue (ttm)16.72M
Revenue per share (ttm)0.58
Quarterly revenue growth (yoy)-13.40%
Gross profit (ttm)-15.66M
EBITDA -110.48M
Net income avi to common (ttm)-94.07M
Diluted EPS (ttm)-4.4820
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.97M
Total cash per share (mrq)3.14
Total debt (mrq)38.98M
Total debt/equity (mrq)50.86
Current ratio (mrq)5.11
Book value per share (mrq)2.70

Cash flow statement

Operating cash flow (ttm)-97.98M
Levered free cash flow (ttm)-62.45M